Lymphoproliferative Disorders clinical trials at UC Irvine

1 research study open to eligible people

Showing trials for

  • DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

    open to eligible people ages 18 years and up

    This is a multicenter, first-in-human, Phase 1/2 study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and anti-tumor activity of DR-01 in adult patients with large granular lymphocytic leukemia or cytotoxic lymphomas

    Irvine, California and other locations

Our lead scientists for Lymphoproliferative Disorders research studies include .

Last updated: